Hormone Receptor Positive Tumor Completed Phase 2 Trials for Anastrozole (DB01217)

IndicationStatusPhase
DBCOND0075370 (Hormone Receptor Positive Tumor)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02441946A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast CancerTreatment